-
Annual General Meeting
Progress on Sahajanand Medical Technologies Limited last Annual general meeting of members was held on 23 Jul 2025 as per latest MCA records. was documented.
-
Director Appointment
The activity Priyanka Dhirajlal Cohen was appointed as a Director was appointed as a Director on 03 Jul 2025 & has been associated with this company since 6 months 23 days . was completed.
-
Director Appointment
The activity Harvinder Pal Singh was appointed as a Director was appointed as a Director on 01 Jul 2025 & has been associated with this company since 6 months 25 days . was completed.
-
Charges
The activity A charge with Others of Rs. 120.00 Cr registered on 26 Apr 2020 with Charge ID 100343858 was modified on 10 Jun 2025. was completed.
-
Director Appointment
The activity Bhargav Dhirajlal Kotadia was appointed as a Ceo was appointed as a Ceo on 25 Apr 2025 & has been associated with this company since 9 months . was completed.
-
Balance Sheet
The activity Sahajanand Medical Technologies Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.
Sahajanand Medical Technologies Limited, a active public limited company, was established on 18 October 2001 in Surat, Gujarat, India. Engaging in medical & laboratory equipment within the manufacturing sector, it holds CIN: U33119GJ2001PLC040121. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹17.00 Cr and a paid-up capital of ₹10.14 Cr.
Formerly known as Sahajanand Medical Technologies Private Limited. It upholds a compliant status. Employing 1,090 professional, Its leadership includes Debasis Panigrahi (Director), Bhargav Dhirajlal Kotadia (Managing Director), Abhishek Rajendrakumar Kabra (Director). Past directors included Debasis Panigrahi, Ashish Mohanlal Agrawal, Ganesh Prasad Sabat. It holds ₹326.32 Cr open charges and ₹573.15 Cr settled loans. Its latest AGM occurred on 23 July 2025, with the balance sheet filed on 31 March 2025. It is based at Sahajanand Estate, Wakharia Wadi Nr. Dabholi Char Rasta, Nani Ved, Ved Ro, Ad,, Surat, Gujarat, 395004.
Company Details
- CIN/LLPIN
U33119GJ2001PLC040121
- Registration Number
040121
- Incorporation Date
18 October 2001
- Authorized Capital
₹17.00 Cr
- Paid-Up Capital
₹10.14 Cr
- ROC Code
Roc Ahmedabad
-
Listing Status
Unlisted
- Company Status
Active
- Authorised Capital ₹ 17.00 Cr
- Paid Up Capital ₹ 10.14 Cr
- Company Age 24 Year, 3 Months
- Last Filing with ROC 31 Mar 2025
- Open Charges ₹ 326.32 Cr
- Satisfied Charges ₹ 573.15 Cr
- Revenue Growth 0.38%
- Profit Growth -255.13%
- Ebitda -63.36%
- Net Worth -4.71%
- Total Assets 6.87%
Sahajanand Medical Technologies Limited
Company Report FY 2025-2026Comprehensive Company Insights
Explore comprehensive insights into Sahajanand Medical Technologies Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Debasis Panigrahi | Director | 22 Sep 2023 | Current |
| Bhargav Dhirajlal Kotadia | Managing Director | 06 May 2013 | Current |
| Abhishek Rajendrakumar Kabra | Director | 28 Dec 2016 | Current |
| Harvinder Pal Singh | Director | 01 Jul 2025 | Current |
| Jose Calle Gordo | Director | 20 Sep 2019 | Current |
| Sonalika Dhar | Director | 30 Jun 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 28 Sep 2023 | Past |
| Pramod Abcsdd | Cfo(Kmp) | 28 Jan 2021 | Past |
| Pramod Abcsdd | Additional Director | 14 Nov 2022 | Past |
| Pramod Abcsdd | Director | 01 Dec 2017 | Past |
| Pramod Abcsdd | Director | 31 Jul 2022 | Past |
| Pramod Abcsdd | Additional Director | 22 Jul 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sahajanand Medical Technologies Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 0.38% increase. The company also saw a substantial fall in profitability, with a 255.13% decrease in profit. The company's net worth dipped by a decrease of 4.71%.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
******* |
******* |
******* |
******* |
||
| Revenue from Operations |
|
******* |
******* |
******* |
******* |
||
| Total Assets |
|
******* |
******* |
******* |
******* |
||
| Profit or Loss |
|
*******
|
*******
|
*******
|
*******
|
||
| Net Worth |
|
*******
|
*******
|
*******
|
*******
|
||
| EBITDA |
|
******* |
******* |
******* |
******* |
In 2020, Sahajanand Medical Technologies had a promoter holding of 44.89% and a public holding of 55.11%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
-
Promoters: 92.83%
-
Public: 4.10%
-
Others: 3.07%
| FY (2024) | FY (2023) | FY (2022) | FY (2021) | FY (2020) | |
|---|---|---|---|---|---|
| Promoters | 92.83 | 94.62 | 94.55 | 94.55 | 94.55 |
| Public | 4.10 | 3.89 | 3.95 | 3.96 | 3.98 |
| Others | 3.07 | 1.49 | 1.50 | 1.49 | 1.47 |
Reveal ownership structures and financial performance - Get instant access now!
₹3,263,170,000.00
₹5,731,529,305.00
- Others : 325.14 Cr
- Hdfc Bank Limited : 1.18 Cr
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Apr 2024 | Others | ₹45.14 Cr | Open |
| 17 Jan 2024 | Others | ₹40.00 Cr | Open |
| 01 Sep 2023 | Hdfc Bank Limited | ₹1.18 Cr | Open |
| 26 Apr 2020 | Others | ₹120.00 Cr | Open |
| 20 Mar 2020 | Others | ₹120.00 Cr | Open |
Explore comprehensive loan charge details -
Sahajanand Medical Technologies has a workforce of 1090 employees as of Feb 08, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
| Employee Date | Number of Employees |
|---|---|
| 2020 | 78,000 |
| 2021 | 80,500 |
| 2022 | 83,200 |
| 2023 | 86,000 |
| 2024 | 89,500 |
| 2025 | 92,000 |
Gain comprehensive insights into the Deals and Valuation data of Sahajanand Medical Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sahajanand Medical Technologies's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
-
-
-
SMT Invests 250 Cr in Telangana, Boosting Medical Device Industry; KTR Applauds Company's Success in 'Make in India' Initiative.
SMT invests 250 Cr in Telangana for medical device unit. KTR happy. SMT makes stents and catheters, creates jobs. Founded in 2001, supports 'Make in India'. Biggest in India, exports to 60+ countries. Has plant in Gujarat and R&D centers. First to get CE certification for drug-eluting stent. Customer-focused and sells directly..
-
-
Indian Stent Supraflex Proven Equal to Global Standard Xience in TALENT Study, SMT Leads the Way in Life-Saving Vascular Solutions.
Indian stent Supraflex confirmed as good as global standard Xience in TALENT study. Supraflex made by SMT, Indian company specializing in life-changing vascular solutions. Study conducted in 7 countries with 1435 patients. Supraflex has better efficacy and lower re-procedure rate. Available in 65 countries, largest selling stent in India. Advanced features like biodegradable polymer and ultra-thin struts. TALENT results match published meta-analysis. CEO proud of India's success in life-saving technology industry. Over 5,00,000 stents used in India every year. Drug eluting stents help prevent artery narrowing after surgery..
-
What is the CIN of Sahajanand Medical Technologies Limited?
The CIN of Sahajanand Medical Technologies Limited is U33119GJ2001PLC040121.
Where is Sahajanand Medical Technologies Limited headquartered?
Sahajanand Medical Technologies Limited is headquartered at Sahajanand Estate, Wakharia Wadi Nr. Dabholi Char Rasta, Nani Ved, Ved Ro, Ad,, Surat, Gujarat, 395004.
When was Sahajanand Medical Technologies Limited incorporated?
Sahajanand Medical Technologies Limited was incorporated on 18 October 2001.
Who are the current directors of Sahajanand Medical Technologies Limited?
The current directors of Sahajanand Medical Technologies Limited are
- Debasis Panigrahi
- Bhargav Dhirajlal Kotadia
- Abhishek Rajendrakumar Kabra
- Harvinder Pal Singh
- Jose Calle Gordo
- Sonalika Dhar
- Dhirajlal Vallabhbhai Kotadia
- Deepshikha Singhal
- Amit Kumar Khandelia
- Bhargav Dhirajlal Kotadia
- Priyanka Dhirajlal Cohen
What is the primary industry of Sahajanand Medical Technologies Limited?
The primary industry of Sahajanand Medical Technologies Limited is Manufacturing.
Is Sahajanand Medical Technologies Limited a listed company?
Sahajanand Medical Technologies Limited is unlisted.
What is the capital structure of Sahajanand Medical Technologies Limited?
The authorized capital of Sahajanand Medical Technologies Limited is ₹17.00 Cr, and the paid-up capital is ₹10.14 Cr.
What is the compliance status of Sahajanand Medical Technologies Limited?
The compliance status of Sahajanand Medical Technologies Limited is Compliant.
+91-XXXXXXXXXX